for 11 straight years, but injuries and a suspension for using a banned substance have kept her off the courts for large chunks of the past four years. Her career earnings of $325 million from prize money, endorsements and appearances rank second all-time among women, behind her longtime adversary Serena Williams .
She continued to rack up sponsorship deals with Land Rover, PepsiCo and Sony coming on board. Nike introduced her line of tennis apparel, and her ballet flat was the best-selling shoe at former Nike subsidiary Cole Haan. in 2015 before her 2016 suspension for using meldonium, which had recently been added to the World Anti-Doping Agency’s list of banned substances. Sharapova said she had taken the drug for a decade because of a family history of diabetes. Her suspension was reduced from two years to 15 months on appeal.
Despite the doping ban, sponsors continued to gravitate to the tennis ace. She inked a multi-year deal with UBS shortly after her suspension ended, and Nike, Evian, Head and Porsche stuck with her.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Forbes - 🏆 394. / 53 Read more »